Kestine (Ebastine)

Ebastine is a selective peripheral H1‑receptor antagonist. By binding to H1 receptors on mast cells and other tissues, it prevents histamine from triggering the cascade that leads to allergy symptoms such as swelling, itching, and mucus production.

The specific dose of Kestine is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical judgment. Dosage information is provided on the prescription label.

Safety data for ebastine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Kestine.

To place an order, submit an enquiry on the Kestine product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kestine (ebastine) is a second‑generation antihistamine, offering effective allergy relief with a lower propensity for sedation compared with first‑generation agents such as diphenhydramine. Its once‑daily dosing and selective H1 blockade make it a convenient option for many patients.

Kestine should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain product stability.

Kestine is taken orally, usually as a tablet swallowed with water. It is typically taken once daily, but the exact timing and any food considerations should follow the prescribing clinician’s instructions.

While rare, serious adverse reactions can include angioedema, severe skin rashes such as Stevens‑Johnson syndrome, anaphylaxis, cardiac arrhythmias, and liver injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Kestine should be avoided in individuals with known hypersensitivity to ebastine or any tablet excipients. Caution is also advised for patients with severe hepatic impairment, and it should only be used during pregnancy or lactation after a risk‑benefit assessment by a healthcare professional.